Piramal Phytocare Limited announced unaudited standalone earnings results for the fourth quarter and audited standalone earnings results for the full year ended March 31, 2017. For the quarter, the company reported net sales income from operations of INR 9.1 million against INR 7.9 million for the same period of last year. Loss from operations before other income, finance costs & exceptional items of INR 4.3 million against INR 15.8 million for the same period of last year. Loss from ordinary activities before tax was INR 3.3 million against loss of INR 14.7 million for the same period of last year. Net loss for the period was INR 3.3 million or INR 0.1 per basic and diluted share before and after extraordinary items against INR 14.7 million or INR 0.6 per basic and diluted share before and after extraordinary items for the same period of last year. For the full year, the company reported the company reported net sales income from operations of INR 41.3 million against INR 63.2 million for the same period of last year. Loss from operations before other income, finance costs & exceptional items of INR 1 million against INR 35 million for the same period of last year. Profit from ordinary activities before tax was INR 19 million against loss of INR 32.4 million for the same period of last year. Net profit for the period was INR 19 million or INR 0.1 per basic and diluted share before and after extraordinary items against loss of INR 32.4 million or INR 1.2 per basic and diluted share before and after extraordinary items for the same period of last year.